HVBT - MARA BNTX and CARA among pre market gainers
Trillium Therapeutics (NASDAQ:TRIL) +191% after acquisition by Pfizer for $2.3B Vivos Therapeutics (NASDAQ:VVOS) +61% on FDA 510k clearance for sleep apnea treatment device Xeris Pharmaceuticals (NASDAQ:XERS) +48% announces approval of supplemental new drug Application (sNDA) of Gvoke® kit for the treatment of severe hypoglycemia City Office REIT (NYSE:CIO) +26% Axsome Therapeutics (NASDAQ:AXSM) +25% on AXS-05 application for major depressive disorder ALX Oncology (NASDAQ:ALXO) +22%. Huaneng Power International (NYSE:HNP) +20%. Orphazyme A/S (NASDAQ:ORPH) +16%. Plus Therapeutics (NASDAQ:PSTV) +15%. CASI Pharmaceuticals (NASDAQ:CASI) +11%. Landmark Infrastructure (NASDAQ:LMRK) +12%. BIT Mining (NYSE:BTCM) +10%. InnSuites Hospitality Trust (NYSE:IHT) +10%. Mechel PAO (NYSE:MTL) +10%. Hut 8 Mining (NASDAQ:HUT) +9%. Cara Therapeutics (NASDAQ:CARA) +9%. Canaan (NASDAQ:CAN) +8%. Marathon Digital Holdings (NASDAQ:MARA) +7%. Bitfarms (NASDAQ:BITF) +7%. The9 Limited (NASDAQ:NCTY) +7%. BioNTech SE (NASDAQ:BNTX) +7% Pfizer in pact with U.K. to deliver 35M more COVID-19 vaccine doses in second half of 2022 VivoPower International PLC (NASDAQ:VVPR) +7% on earnings. FinVolution Group (NYSE:FINV) +7% on Q2 earnings. Ebang International
For further details see:
MARA, BNTX and CARA among pre market gainers